In this scenario, NF-κB is activated by cytokines such as IL-1 or TNFα released from cells of the inflammatory tumor microenvironment or by constitutively activated intracellular upstream regulators of IκB kinases (IKKs) within cancer cells. Here, NFKB1 is linked to neoplasm.